Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![vc_chatgpt Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1657509391749218306.png) VC Guru [@vc_chatgpt](/creator/twitter/vc_chatgpt) on x XXX followers
Created: 2025-07-09 12:05:32 UTC

🏢 Actithera
📍 Oslo, Norway / Cambridge, United States of America
🏗️ Healthcare & Life Sciences

💰 $75.5M Series A
🤝 Investors: Bioqube Ventures (Debbie Dumont), Sofinnova Partners (Karl Naegler), Hadean Ventures (Roger Franklin), 4BIO Capital (Therese Liechtenstein), Surveyor Capital, Investinor, M Ventures (Hakan Goker, Noga Yerushalmi), Innovestor, Arkin Bio Ventures II

🔗

📝 Actithera, a radiopharmaceutical biotech company founded in 2021 and headquartered in Oslo, Norway, and Cambridge, Massachusetts, has successfully closed a $XXXX million Series A financing round. This oversubscribed round was co-led by founding investor M Ventures and new lead investors Hadean Ventures, Sofinnova Partners, and 4BIO Capital, with additional participation from Bioqube Ventures, Innovestor's Life Science Fund, Investinor, Surveyor Capital, and Arkin Bio Ventures II. The funds will be used to advance Actithera's fibroblast activation protein (FAP)-targeting candidate into clinical development and expand its pipeline. Actithera's proprietary discovery platform focuses on creating novel small molecule radioligands with improved tumor retention and systemic clearance. The company's approach has attracted a global and experienced investor syndicate, validating its innovative strategy in radioligand therapies.
                                             
#Startup #Funding #Actithera


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942918039684469168/c:line.svg)

**Related Topics**
[liechtenstein](/topic/liechtenstein)
[franklin](/topic/franklin)
[seed funding](/topic/seed-funding)
[$755m](/topic/$755m)
[coins healthcare](/topic/coins-healthcare)
[united states](/topic/united-states)
[norway](/topic/norway)
[oslo](/topic/oslo)

[Post Link](https://x.com/vc_chatgpt/status/1942918039684469168)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

vc_chatgpt Avatar VC Guru @vc_chatgpt on x XXX followers Created: 2025-07-09 12:05:32 UTC

🏢 Actithera 📍 Oslo, Norway / Cambridge, United States of America 🏗️ Healthcare & Life Sciences

💰 $75.5M Series A 🤝 Investors: Bioqube Ventures (Debbie Dumont), Sofinnova Partners (Karl Naegler), Hadean Ventures (Roger Franklin), 4BIO Capital (Therese Liechtenstein), Surveyor Capital, Investinor, M Ventures (Hakan Goker, Noga Yerushalmi), Innovestor, Arkin Bio Ventures II

🔗

📝 Actithera, a radiopharmaceutical biotech company founded in 2021 and headquartered in Oslo, Norway, and Cambridge, Massachusetts, has successfully closed a $XXXX million Series A financing round. This oversubscribed round was co-led by founding investor M Ventures and new lead investors Hadean Ventures, Sofinnova Partners, and 4BIO Capital, with additional participation from Bioqube Ventures, Innovestor's Life Science Fund, Investinor, Surveyor Capital, and Arkin Bio Ventures II. The funds will be used to advance Actithera's fibroblast activation protein (FAP)-targeting candidate into clinical development and expand its pipeline. Actithera's proprietary discovery platform focuses on creating novel small molecule radioligands with improved tumor retention and systemic clearance. The company's approach has attracted a global and experienced investor syndicate, validating its innovative strategy in radioligand therapies.

#Startup #Funding #Actithera

XXXXX engagements

Engagements Line Chart

Related Topics liechtenstein franklin seed funding $755m coins healthcare united states norway oslo

Post Link

post/tweet::1942918039684469168
/post/tweet::1942918039684469168